Mentions:
1: Baroness Cumberlege (Con - Life peer) valproate and pelvic mesh, published on 7 February. - Speech Link
2: Lord Markham (Con - Life peer) valproate and pelvic mesh. - Speech Link
3: Baroness Uddin (Non-affiliated - Life peer) On previous occasions, I have raised my ongoing concerns about the use of sodium valproate, especially - Speech Link
4: Baroness Bennett of Manor Castle (Green - Life peer) valproate and vaginal mesh victims. - Speech Link
Feb. 22 2024
Source Page: NI Sodium Valproate Monitoring Report, July to December 2023Found: NI Sodium Valproate Monitoring Report, July to December 2023
Feb. 22 2024
Source Page: NI Sodium Valproate Monitoring Report, July to December 2023Found: NI Sodium Valproate Monitoring Report, July to December 2023
Asked by: Justin Madders (Labour - Ellesmere Port and Neston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what her planned timetable is for publishing a response to the Hughes Report on compensation for patients damaged by sodium valproate, published 7 February 2024.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report, and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations, and will respond substantively in due course.
Asked by: Cat Smith (Labour - Lancaster and Fleetwood)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to The Hughes Report, published on 7 February 2024, if she will make an assessment of the potential merits of providing interim payments to victims of sodium valproate.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations and will respond substantively in due course.
Asked by: Daniel Kawczynski (Conservative - Shrewsbury and Atcham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that men who have taken Sodium Valproate receive compensation for (a) fertility and (b) other health effect.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Our sympathies remain with those affected by sodium valproate. The Government is carefully considering the Patient Safety Commissioner’s recommendations as set out in the Hughes Report: Options for redress for those harmed by valproate and pelvic mesh, published on 7 February 2024, and will respond substantively in due course.
As part of the Medicines and Healthcare products Regulatory Agency’s ongoing monitoring of valproate safety, we continue to rigorously review all emerging data on valproate.
Asked by: Cat Smith (Labour - Lancaster and Fleetwood)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she plans to meet with (a) patient groups and (b) campaigners representing people affected by sodium valproate harm in pregnancy.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. As part of this work the Government asked the PSC to seek views from those affected about what redress would be appropriate. The PSC has engaged with patients and patient groups in preparing her report.
We are grateful to the PSC and her team for completing this report and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations and will respond substantively in due course.
Correspondence Nov. 29 2023
Committee: Health and Social Care Committee (Department: Department of Health and Social Care)Found: Correspondence from Patient Safety Commissioner to the Chair on Sodium valproate 16.11.23 Correspondence
Asked by: Siobhan Baillie (Conservative - Stroud)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what her Department's timescales are for responding to The Hughes Report, published by the Patient Safety Commissioner on 7 February 2024.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report, and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations and will respond substantively in due course. Bowel mesh, also known as rectopexy mesh, did not fall within the definition of pelvic organ prolapse that the PSC investigated for her report.
Asked by: Cat Smith (Labour - Lancaster and Fleetwood)
Question to the HM Treasury:
To ask the Chancellor of the Exchequer, if he will make provision for compensation to those affected by sodium valproate in the forthcoming Budget.
Answered by Laura Trott - Chief Secretary to the Treasury
On 7 February, the Patient Safety Commissioner published The Hughes Report, which provides recommendations for redress for those harmed by valproate and pelvic mesh.
The Government is carefully considering these recommendations and will respond to the report in due course.